NDC 47781-683

Rasagiline

Rasagiline

Rasagiline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen, Inc.. The primary component is Rasagiline Mesylate.

• Product ID: 47781-683_5cd32f18-1118-27a0-5b9f-439a4c35f9b5
• NDC: 47781-683
• Product Type: Human Prescription Drug
• Proprietary Name: Rasagiline
• Generic Name: Rasagiline
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2019-03-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA201970
• Labeler Name: Alvogen, Inc.
• Substance Name: RASAGILINE MESYLATE
• Active Ingredient Strength: 1 mg/1
• Pharm Classes: Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 47781-683-30

30 TABLET in 1 BOTTLE, PLASTIC (47781-683-30)

• Marketing Start Date: 2019-03-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 47781-683-30 [47781068330]

Rasagiline TABLET

• Marketing Category: ANDA
• Application Number: ANDA201970
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-03-01

Drug Details

Active Ingredients

Ingredient	Strength
RASAGILINE MESYLATE	.5 mg/1

OpenFDA Data

• SPL SET ID: a62a9946-755f-47d0-afe6-edc8f7d641fe
• Manufacturer:
  • Alvogen, Inc.
• UNII:
  • LH8C2JI290

Pharmacological Class

• Monoamine Oxidase Inhibitor [EPC]
• Monoamine Oxidase Inhibitors [MoA]

NDC Crossover Matching brand name "Rasagiline" or generic name "Rasagiline"

NDC	Brand Name	Generic Name
0093-3060	Rasagiline	Rasagiline
0093-3061	Rasagiline	Rasagiline
16714-770	Rasagiline	Rasagiline
16714-771	Rasagiline	Rasagiline
42291-779	Rasagiline	Rasagiline
42291-780	Rasagiline	Rasagiline
42571-220	RASAGILINE	Rasagiline
42571-221	RASAGILINE	Rasagiline
47781-683	Rasagiline	Rasagiline
47781-690	Rasagiline	Rasagiline
67877-259	Rasagiline	Rasagiline
67877-260	Rasagiline	Rasagiline